Q32 Bio, Inc. (QTTB)
16.36
+0.39
(+2.44%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
-0.02
(-0.12%)
Pre-Market: 20:00
Q32 Bio Enterprise Value : 287.36M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 287.36M |
| August 21, 2026 | 278.10M |
| August 20, 2026 | 275.49M |
| August 19, 2026 | 275.01M |
| August 18, 2026 | 261.96M |
| August 17, 2026 | 277.62M |
| August 14, 2026 | 258.64M |
| August 13, 2026 | 263.86M |
| August 12, 2026 | 263.86M |
| August 11, 2026 | 264.81M |
| August 10, 2026 | 270.98M |
| August 07, 2026 | 269.32M |
| August 06, 2026 | 283.56M |
| August 05, 2026 | 290.44M |
| August 04, 2026 | 282.49M |
| August 03, 2026 | 258.99M |
| July 31, 2026 | 271.22M |
| July 30, 2026 | 268.37M |
| July 29, 2026 | 246.53M |
| July 28, 2026 | 271.93M |
| July 27, 2026 | 260.06M |
| July 24, 2026 | 258.64M |
| July 23, 2026 | 264.09M |
| July 22, 2026 | 256.97M |
| July 21, 2026 | 264.81M |
| Date | Value |
|---|---|
| July 20, 2026 | 256.02M |
| July 17, 2026 | 256.26M |
| July 16, 2026 | 260.06M |
| July 15, 2026 | 271.69M |
| July 14, 2026 | 337.20M |
| July 13, 2026 | 406.51M |
| July 10, 2026 | 165.11M |
| July 09, 2026 | 197.87M |
| July 08, 2026 | 233.24M |
| July 07, 2026 | 222.32M |
| July 06, 2026 | 204.40M |
| July 02, 2026 | 209.74M |
| July 01, 2026 | 198.11M |
| June 30, 2026 | 201.43M |
| June 29, 2026 | 169.76M |
| June 26, 2026 | 155.57M |
| June 25, 2026 | 137.72M |
| June 24, 2026 | 126.16M |
| June 23, 2026 | 136.69M |
| June 22, 2026 | 147.96M |
| June 18, 2026 | 136.99M |
| June 17, 2026 | 151.76M |
| June 16, 2026 | 149.42M |
| June 15, 2026 | 151.03M |
| June 12, 2026 | 147.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Rallybio Corp. | -3.693M |
| Beam Therapeutics, Inc. | 2.020B |
| C4 Therapeutics, Inc. | 307.11M |
| Arrowhead Pharmaceuticals, Inc. | 12.02B |
| Oncolytics Biotech, Inc. | 101.54M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.946M |
| Total Expenses (Quarterly) | 8.946M |
| EPS Diluted (Quarterly) | -0.4398 |
| Earnings Yield | 18.35% |
| Operating Earnings Yield | 8.85% |
| Normalized Earnings Yield | 18.38 |